The global Plant Metabolomics market is projected to grow from US$ 1316 million in 2024 to US$ 2144 million by 2031, at a CAGR of 7.3% (2025-2031), driven by critical product segments and diverse end‑use applications.

Plant Metabolomics Market

Plant Metabolomics is an important branch of metabolomics, which is defined as metabolomics with plants as the research object; it studies all small molecule metabolites of plants of different species, different gene types or different ecological types at different growth periods or before and after certain stimulation, conducts qualitative and quantitative analysis, and finds out the laws of metabolic changes. In order to survive in a constantly changing and harsh environment, plants have evolved complex, multicellular structures with different functional organs; these organs contain a variety of cell types, and these different types of cells have transferred metabolic mechanisms to accurately realize their specific functions. The effects of environment, temperature and season are compensated by metabolic changes; due to the stress effects of abiotic (light, ultraviolet rays, water) and biotic (insect pests, parasites and pathogens), plants derive a complex library of metabolic compounds. There are both primary metabolites necessary to maintain plant life activities and growth and development, and secondary metabolites generated by primary metabolites that are closely related to plant disease resistance and stress resistance.

From a downstream perspective, Plant Breeding accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).

Plant Metabolomics leading manufacturers including Creative Dynamics Inc (Creative Proteomics), MtoZ-Biolabs Inc., Lifeasible, BGI Genomics, DNA Xperts, Novogene, BASF, ProDigest, Metabolon, Inc., CD Genomics, etc., dominate supply; the top five capture approximately % of global revenue, with Creative Dynamics Inc (Creative Proteomics) leading 2024 sales at US$ million.

Regional Outlook:

North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).

Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).

Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Plant Metabolomics market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.

Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.

Market Segmentation

Scope of Plant Metabolomics Market Report

Report Metric	Details
Report Name	Plant Metabolomics Market
Accounted market size in 2024	US$ 1316 in million
Forecasted market size in 2031	US$ 2144 million
CAGR	7.3%
Base Year	2024
Forecasted years	2025 - 2031
Segment by Type	Plant Targeted Metabolomics Plant Non-targeted Metabolomics
Segment by Application	Plant Breeding Medicinal Plant Research Biomarker Development Food Science
Sales by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Creative Dynamics Inc (Creative Proteomics), MtoZ-Biolabs Inc., Lifeasible, BGI Genomics, DNA Xperts, Novogene, BASF, ProDigest, Metabolon, Inc., CD Genomics, Alfa Chemistry, Metware Biotechnology Inc (Metware), Biotech Pack, APPLIED PROTEIN TECHNOLOGY, Bioprofile, TianGen
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the Plant Metabolomics study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

How fast is Plant Metabolomics Market growing?

Ans: The Plant Metabolomics Market witnessing a CAGR of 7.3% during the forecast period 2025-2031.

What is the Plant Metabolomics Market size in 2031?

Ans: The Plant Metabolomics Market size in 2031 will be US$ 2144 million.

Who are the main players in the Plant Metabolomics Market report?

Ans: The main players in the Plant Metabolomics Market are Creative Dynamics Inc (Creative Proteomics), MtoZ-Biolabs Inc., Lifeasible, BGI Genomics, DNA Xperts, Novogene, BASF, ProDigest, Metabolon, Inc., CD Genomics, Alfa Chemistry, Metware Biotechnology Inc (Metware), Biotech Pack, APPLIED PROTEIN TECHNOLOGY, Bioprofile, TianGen

What are the Application segmentation covered in the Plant Metabolomics Market report?

Ans: The Applications covered in the Plant Metabolomics Market report are Plant Breeding, Medicinal Plant Research, Biomarker Development, Food Science

What are the Type segmentation covered in the Plant Metabolomics Market report?

Ans: The Types covered in the Plant Metabolomics Market report are Plant Targeted Metabolomics, Plant Non-targeted Metabolomics

1 Study Coverage

1.1 Introduction to Plant Metabolomics: Definition, Properties, and Key Attributes

1.2 Market Segmentation by Type

1.2.1 Global Plant Metabolomics Market Size by Type, 2020 VS 2024 VS 2031

1.2.2 Plant Targeted Metabolomics

1.2.3 Plant Non-targeted Metabolomics

1.3 Market Segmentation by Application

1.3.1 Global Plant Metabolomics Market Size by Application, 2020 VS 2024 VS 2031

1.3.2 Plant Breeding

1.3.3 Medicinal Plant Research

1.3.4 Biomarker Development

1.3.5 Food Science

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Plant Metabolomics Revenue Estimates and Forecasts 2020-2031

2.2 Global Plant Metabolomics Revenue by Region

2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031

2.2.2 Historical and Forecasted Revenue by Region (2020-2031)

2.2.3 Global Revenue Market Share by Region (2020-2031)

2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends

3 Competition by Players

3.1 Global Plant Metabolomics Player Revenue Rankings and Profitability

3.1.1 Global Revenue (Value) by Players (2020-2025)

3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)

3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)

3.1.4 Gross Margin by Top Player (2020 VS 2024)

3.2 Global Plant Metabolomics Companies Headquarters and Service Footprint

3.3 Main Product Type Market Size by Players

3.3.1 Plant Targeted Metabolomics Market Size by Players

3.3.2 Plant Non-targeted Metabolomics Market Size by Players

3.4 Global Plant Metabolomics Market Concentration and Dynamics

3.4.1 Global Market Concentration (CR5 and HHI)

3.4.2 Entrant/Exit Impact Analysis

3.4.3 Strategic Moves: M&A, Expansion, R&D Investment

4 Global Product Segmentation Analysis

4.1 Global Plant Metabolomics Revenue Trends by Type

4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)

4.1.2 Global Revenue Market Share by Type (2020-2031)

4.2 Key Product Attributes and Differentiation

4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk

4.3.1 High-Growth Niches and Adoption Drivers

4.3.2 Profitability Hotspots and Cost Drivers

4.3.3 Substitution Threats

5 Global Downstream Application Analysis

5.1 Global Plant Metabolomics Revenue by Application

5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)

5.1.2 Revenue Market Share by Application (2020-2031)

5.1.3 High-Growth Application Identification

5.1.4 Emerging Application Case Studies

5.2 Downstream Customer Analysis

5.2.1 Top Customers by Region

5.2.2 Top Customers by Application

6 North America

6.1 North America Market Size (2020-2031)

6.2 North America Key Players Revenue in 2024

6.3 North America Plant Metabolomics Market Size by Type (2020-2031)

6.4 North America Plant Metabolomics Market Size by Application (2020-2031)

6.5 North America Growth Accelerators and Market Barriers

6.6 North America Plant Metabolomics Market Size by Country

6.6.1 North America Revenue Trends by Country

6.6.2 US

6.6.3 Canada

6.6.4 Mexico

7 Europe

7.1 Europe Market Size (2020-2031)

7.2 Europe Key Players Revenue in 2024

7.3 Europe Plant Metabolomics Market Size by Type (2020-2031)

7.4 Europe Plant Metabolomics Market Size by Application (2020-2031)

7.5 Europe Growth Accelerators and Market Barriers

7.6 Europe Plant Metabolomics Market Size by Country

7.6.1 Europe Revenue Trends by Country

7.6.2 Germany

7.6.3 France

7.6.4 U.K.

7.6.5 Italy

7.6.6 Russia

8 Asia-Pacific

8.1 Asia-Pacific Market Size (2020-2031)

8.2 Asia-Pacific Key Players Revenue in 2024

8.3 Asia-Pacific Plant Metabolomics Market Size by Type (2020-2031)

8.4 Asia-Pacific Plant Metabolomics Market Size by Application (2020-2031)

8.5 Asia-Pacific Growth Accelerators and Market Barriers

8.6 Asia-Pacific Plant Metabolomics Market Size by Region

8.6.1 Asia-Pacific Revenue Trends by Region

8.7 China

8.8 Japan

8.9 South Korea

8.10 Australia

8.11 India

8.12 Southeast Asia

8.12.1 Indonesia

8.12.2 Vietnam

8.12.3 Malaysia

8.12.4 Philippines

8.12.5 Singapore

9 Central and South America

9.1 Central and South America Market Size (2020-2031)

9.2 Central and South America Key Players Revenue in 2024

9.3 Central and South America Plant Metabolomics Market Size by Type (2020-2031)

9.4 Central and South America Plant Metabolomics Market Size by Application (2020-2031)

9.5 Central and South America Investment Opportunities and Key Challenges

9.6 Central and South America Plant Metabolomics Market Size by Country

9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)

9.6.2 Brazil

9.6.3 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Market Size (2020-2031)

10.2 Middle East and Africa Key Players Revenue in 2024

10.3 Middle East and Africa Plant Metabolomics Market Size by Type (2020-2031)

10.4 Middle East and Africa Plant Metabolomics Market Size by Application (2020-2031)

10.5 Middle East and Africa Investment Opportunities and Key Challenges

10.6 Middle East and Africa Plant Metabolomics Market Size by Country

10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)

10.6.2 GCC Countries

10.6.3 Israel

10.6.4 Egypt

10.6.5 South Africa

11 Corporate Profile

11.1 Creative Dynamics Inc (Creative Proteomics)

11.1.1 Creative Dynamics Inc (Creative Proteomics) Corporation Information

11.1.2 Creative Dynamics Inc (Creative Proteomics) Business Overview

11.1.3 Creative Dynamics Inc (Creative Proteomics) Plant Metabolomics Product Features and Attributes

11.1.4 Creative Dynamics Inc (Creative Proteomics) Plant Metabolomics Revenue and Gross Margin (2020-2025)

11.1.5 Creative Dynamics Inc (Creative Proteomics) Plant Metabolomics Revenue by Product in 2024

11.1.6 Creative Dynamics Inc (Creative Proteomics) Plant Metabolomics Revenue by Application in 2024

11.1.7 Creative Dynamics Inc (Creative Proteomics) Plant Metabolomics Revenue by Geographic Area in 2024

11.1.8 Creative Dynamics Inc (Creative Proteomics) Plant Metabolomics SWOT Analysis

11.1.9 Creative Dynamics Inc (Creative Proteomics) Recent Developments

11.2 MtoZ-Biolabs Inc.

11.2.1 MtoZ-Biolabs Inc. Corporation Information

11.2.2 MtoZ-Biolabs Inc. Business Overview

11.2.3 MtoZ-Biolabs Inc. Plant Metabolomics Product Features and Attributes

11.2.4 MtoZ-Biolabs Inc. Plant Metabolomics Revenue and Gross Margin (2020-2025)

11.2.5 MtoZ-Biolabs Inc. Plant Metabolomics Revenue by Product in 2024

11.2.6 MtoZ-Biolabs Inc. Plant Metabolomics Revenue by Application in 2024

11.2.7 MtoZ-Biolabs Inc. Plant Metabolomics Revenue by Geographic Area in 2024

11.2.8 MtoZ-Biolabs Inc. Plant Metabolomics SWOT Analysis

11.2.9 MtoZ-Biolabs Inc. Recent Developments

11.3 Lifeasible

11.3.1 Lifeasible Corporation Information

11.3.2 Lifeasible Business Overview

11.3.3 Lifeasible Plant Metabolomics Product Features and Attributes

11.3.4 Lifeasible Plant Metabolomics Revenue and Gross Margin (2020-2025)

11.3.5 Lifeasible Plant Metabolomics Revenue by Product in 2024

11.3.6 Lifeasible Plant Metabolomics Revenue by Application in 2024

11.3.7 Lifeasible Plant Metabolomics Revenue by Geographic Area in 2024

11.3.8 Lifeasible Plant Metabolomics SWOT Analysis

11.3.9 Lifeasible Recent Developments

11.4 BGI Genomics

11.4.1 BGI Genomics Corporation Information

11.4.2 BGI Genomics Business Overview

11.4.3 BGI Genomics Plant Metabolomics Product Features and Attributes

11.4.4 BGI Genomics Plant Metabolomics Revenue and Gross Margin (2020-2025)

11.4.5 BGI Genomics Plant Metabolomics Revenue by Product in 2024

11.4.6 BGI Genomics Plant Metabolomics Revenue by Application in 2024

11.4.7 BGI Genomics Plant Metabolomics Revenue by Geographic Area in 2024

11.4.8 BGI Genomics Plant Metabolomics SWOT Analysis

11.4.9 BGI Genomics Recent Developments

11.5 DNA Xperts

11.5.1 DNA Xperts Corporation Information

11.5.2 DNA Xperts Business Overview

11.5.3 DNA Xperts Plant Metabolomics Product Features and Attributes

11.5.4 DNA Xperts Plant Metabolomics Revenue and Gross Margin (2020-2025)

11.5.5 DNA Xperts Plant Metabolomics Revenue by Product in 2024

11.5.6 DNA Xperts Plant Metabolomics Revenue by Application in 2024

11.5.7 DNA Xperts Plant Metabolomics Revenue by Geographic Area in 2024

11.5.8 DNA Xperts Plant Metabolomics SWOT Analysis

11.5.9 DNA Xperts Recent Developments

11.6 Novogene

11.6.1 Novogene Corporation Information

11.6.2 Novogene Business Overview

11.6.3 Novogene Plant Metabolomics Product Features and Attributes

11.6.4 Novogene Plant Metabolomics Revenue and Gross Margin (2020-2025)

11.6.5 Novogene Recent Developments

11.7 BASF

11.7.1 BASF Corporation Information

11.7.2 BASF Business Overview

11.7.3 BASF Plant Metabolomics Product Features and Attributes

11.7.4 BASF Plant Metabolomics Revenue and Gross Margin (2020-2025)

11.7.5 BASF Recent Developments

11.8 ProDigest

11.8.1 ProDigest Corporation Information

11.8.2 ProDigest Business Overview

11.8.3 ProDigest Plant Metabolomics Product Features and Attributes

11.8.4 ProDigest Plant Metabolomics Revenue and Gross Margin (2020-2025)

11.8.5 ProDigest Recent Developments

11.9 Metabolon, Inc.

11.9.1 Metabolon, Inc. Corporation Information

11.9.2 Metabolon, Inc. Business Overview

11.9.3 Metabolon, Inc. Plant Metabolomics Product Features and Attributes

11.9.4 Metabolon, Inc. Plant Metabolomics Revenue and Gross Margin (2020-2025)

11.9.5 Metabolon, Inc. Recent Developments

11.10 CD Genomics

11.10.1 CD Genomics Corporation Information

11.10.2 CD Genomics Business Overview

11.10.3 CD Genomics Plant Metabolomics Product Features and Attributes

11.10.4 CD Genomics Plant Metabolomics Revenue and Gross Margin (2020-2025)

11.10.5 Company Ten Recent Developments

11.11 Alfa Chemistry

11.11.1 Alfa Chemistry Corporation Information

11.11.2 Alfa Chemistry Business Overview

11.11.3 Alfa Chemistry Plant Metabolomics Product Features and Attributes

11.11.4 Alfa Chemistry Plant Metabolomics Revenue and Gross Margin (2020-2025)

11.11.5 Alfa Chemistry Recent Developments

11.12 Metware Biotechnology Inc (Metware)

11.12.1 Metware Biotechnology Inc (Metware) Corporation Information

11.12.2 Metware Biotechnology Inc (Metware) Business Overview

11.12.3 Metware Biotechnology Inc (Metware) Plant Metabolomics Product Features and Attributes

11.12.4 Metware Biotechnology Inc (Metware) Plant Metabolomics Revenue and Gross Margin (2020-2025)

11.12.5 Metware Biotechnology Inc (Metware) Recent Developments

11.13 Biotech Pack

11.13.1 Biotech Pack Corporation Information

11.13.2 Biotech Pack Business Overview

11.13.3 Biotech Pack Plant Metabolomics Product Features and Attributes

11.13.4 Biotech Pack Plant Metabolomics Revenue and Gross Margin (2020-2025)

11.13.5 Biotech Pack Recent Developments

11.14 APPLIED PROTEIN TECHNOLOGY

11.14.1 APPLIED PROTEIN TECHNOLOGY Corporation Information

11.14.2 APPLIED PROTEIN TECHNOLOGY Business Overview

11.14.3 APPLIED PROTEIN TECHNOLOGY Plant Metabolomics Product Features and Attributes

11.14.4 APPLIED PROTEIN TECHNOLOGY Plant Metabolomics Revenue and Gross Margin (2020-2025)

11.14.5 APPLIED PROTEIN TECHNOLOGY Recent Developments

11.15 Bioprofile

11.15.1 Bioprofile Corporation Information

11.15.2 Bioprofile Business Overview

11.15.3 Bioprofile Plant Metabolomics Product Features and Attributes

11.15.4 Bioprofile Plant Metabolomics Revenue and Gross Margin (2020-2025)

11.15.5 Bioprofile Recent Developments

11.16 TianGen

11.16.1 TianGen Corporation Information

11.16.2 TianGen Business Overview

11.16.3 TianGen Plant Metabolomics Product Features and Attributes

11.16.4 TianGen Plant Metabolomics Revenue and Gross Margin (2020-2025)

11.16.5 TianGen Recent Developments

12 Plant MetabolomicsIndustry Chain Analysis

12.1 Plant Metabolomics Industry Chain

12.2 Upstream Analysis

12.2.1 Upstream Key Suppliers

12.3 Middlestream Analysis

12.4 Downstream Sales Model and Distribution Networks

12.4.1 Sales Channels

12.4.2 Distributors

13 Plant Metabolomics Market Dynamics

13.1 Industry Trends and Evolution

13.2 Market Growth Drivers and Emerging Opportunities

13.3 Market Challenges, Risks, and Restraints

14 Key Findings in the Global Plant Metabolomics Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

15.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Author Details

FEATURED COMPANIES

Creative Dynamics Inc (Creative Proteomics)

Metware Biotechnology Inc (Metware)

Biotech Pack

Applied Protein Technology

TIANGEN

DNA Xperts

Bioprofile

List of Tables

Table 1. Global Plant Metabolomics Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Table 2. Global Plant Metabolomics Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Table 3. Global Plant Metabolomics Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 4. Global Plant Metabolomics Revenue by Region (2020-2025) & (US$ Million)

Table 5. Global Plant Metabolomics Revenue by Region (2026-2031) & (US$ Million)

Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 7. Global Plant Metabolomics Revenue by Players (2020-2025) & (US$ Million)

Table 8. Global Plant Metabolomics Revenue Market Share by Players (2020-2025)

Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)

Table 10. Global Plant Metabolomics by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plant Metabolomics as of 2024)

Table 11. Global Plant Metabolomics Average Gross Margin (%) by Player (2020 VS 2024)

Table 12. Global Plant Metabolomics Companies Headquarters

Table 13. Global Plant Metabolomics Market Concentration Ratio (CR5 and HHI)

Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis

Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment

Table 16. Global Plant Metabolomics Revenue by Type (2020-2025) & (US$ Million)

Table 17. Global Plant Metabolomics Revenue by Type (2026-2031) & (US$ Million)

Table 18. Key Product Attributes and Differentiation

Table 19. Global Plant Metabolomics Revenue by Application (2020-2025) & (US$ Million)

Table 20. Global Plant Metabolomics Revenue by Application (2026-2031) & (US$ Million)

Table 21. Plant Metabolomics High-Growth Sectors Demand CAGR (2024-2031)

Table 22. Top Customers by Region

Table 23. Top Customers by Application

Table 24. North America Plant Metabolomics Growth Accelerators and Market Barriers

Table 25. North America Plant Metabolomics Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 26. Europe Plant Metabolomics Growth Accelerators and Market Barriers

Table 27. Europe Plant Metabolomics Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 28. Asia-Pacific Plant Metabolomics Growth Accelerators and Market Barriers

Table 29. Asia-Pacific Plant Metabolomics Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 30. Central and South America Plant Metabolomics Investment Opportunities and Key Challenges

Table 31. Central and South America Plant Metabolomics Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 32. Middle East and Africa Plant Metabolomics Investment Opportunities and Key Challenges

Table 33. Middle East and Africa Plant Metabolomics Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 34. Creative Dynamics Inc (Creative Proteomics) Corporation Information

Table 35. Creative Dynamics Inc (Creative Proteomics) Description and Major Businesses

Table 36. Creative Dynamics Inc (Creative Proteomics) Product Features and Attributes

Table 37. Creative Dynamics Inc (Creative Proteomics) Revenue (US$ Million) and Gross Margin (2020-2025)

Table 38. Creative Dynamics Inc (Creative Proteomics) Revenue Proportion by Product in 2024

Table 39. Creative Dynamics Inc (Creative Proteomics) Revenue Proportion by Application in 2024

Table 40. Creative Dynamics Inc (Creative Proteomics) Revenue Proportion by Geographic Area in 2024

Table 41. Creative Dynamics Inc (Creative Proteomics) Plant Metabolomics SWOT Analysis

Table 42. Creative Dynamics Inc (Creative Proteomics) Recent Developments

Table 43. MtoZ-Biolabs Inc. Corporation Information

Table 44. MtoZ-Biolabs Inc. Description and Major Businesses

Table 45. MtoZ-Biolabs Inc. Product Features and Attributes

Table 46. MtoZ-Biolabs Inc. Revenue (US$ Million) and Gross Margin (2020-2025)

Table 47. MtoZ-Biolabs Inc. Revenue Proportion by Product in 2024

Table 48. MtoZ-Biolabs Inc. Revenue Proportion by Application in 2024

Table 49. MtoZ-Biolabs Inc. Revenue Proportion by Geographic Area in 2024

Table 50. MtoZ-Biolabs Inc. Plant Metabolomics SWOT Analysis

Table 51. MtoZ-Biolabs Inc. Recent Developments

Table 52. Lifeasible Corporation Information

Table 53. Lifeasible Description and Major Businesses

Table 54. Lifeasible Product Features and Attributes

Table 55. Lifeasible Revenue (US$ Million) and Gross Margin (2020-2025)

Table 56. Lifeasible Revenue Proportion by Product in 2024

Table 57. Lifeasible Revenue Proportion by Application in 2024

Table 58. Lifeasible Revenue Proportion by Geographic Area in 2024

Table 59. Lifeasible Plant Metabolomics SWOT Analysis

Table 60. Lifeasible Recent Developments

Table 61. BGI Genomics Corporation Information

Table 62. BGI Genomics Description and Major Businesses

Table 63. BGI Genomics Product Features and Attributes

Table 64. BGI Genomics Revenue (US$ Million) and Gross Margin (2020-2025)

Table 65. BGI Genomics Revenue Proportion by Product in 2024

Table 66. BGI Genomics Revenue Proportion by Application in 2024

Table 67. BGI Genomics Revenue Proportion by Geographic Area in 2024

Table 68. BGI Genomics Plant Metabolomics SWOT Analysis

Table 69. BGI Genomics Recent Developments

Table 70. DNA Xperts Corporation Information

Table 71. DNA Xperts Description and Major Businesses

Table 72. DNA Xperts Product Features and Attributes

Table 73. DNA Xperts Revenue (US$ Million) and Gross Margin (2020-2025)

Table 74. DNA Xperts Revenue Proportion by Product in 2024

Table 75. DNA Xperts Revenue Proportion by Application in 2024

Table 76. DNA Xperts Revenue Proportion by Geographic Area in 2024

Table 77. DNA Xperts Plant Metabolomics SWOT Analysis

Table 78. DNA Xperts Recent Developments

Table 79. Novogene Corporation Information

Table 80. Novogene Description and Major Businesses

Table 81. Novogene Product Features and Attributes

Table 82. Novogene Revenue (US$ Million) and Gross Margin (2020-2025)

Table 83. Novogene Recent Developments

Table 84. BASF Corporation Information

Table 85. BASF Description and Major Businesses

Table 86. BASF Product Features and Attributes

Table 87. BASF Revenue (US$ Million) and Gross Margin (2020-2025)

Table 88. BASF Recent Developments

Table 89. ProDigest Corporation Information

Table 90. ProDigest Description and Major Businesses

Table 91. ProDigest Product Features and Attributes

Table 92. ProDigest Revenue (US$ Million) and Gross Margin (2020-2025)

Table 93. ProDigest Recent Developments

Table 94. Metabolon, Inc. Corporation Information

Table 95. Metabolon, Inc. Description and Major Businesses

Table 96. Metabolon, Inc. Product Features and Attributes

Table 97. Metabolon, Inc. Revenue (US$ Million) and Gross Margin (2020-2025)

Table 98. Metabolon, Inc. Recent Developments

Table 99. CD Genomics Corporation Information

Table 100. CD Genomics Description and Major Businesses

Table 101. CD Genomics Product Features and Attributes

Table 102. CD Genomics Revenue (US$ Million) and Gross Margin (2020-2025)

Table 103. CD Genomics Recent Developments

Table 104. Alfa Chemistry Corporation Information

Table 105. Alfa Chemistry Description and Major Businesses

Table 106. Alfa Chemistry Product Features and Attributes

Table 107. Alfa Chemistry Revenue (US$ Million) and Gross Margin (2020-2025)

Table 108. Alfa Chemistry Recent Developments

Table 109. Metware Biotechnology Inc (Metware) Corporation Information

Table 110. Metware Biotechnology Inc (Metware) Description and Major Businesses

Table 111. Metware Biotechnology Inc (Metware) Product Features and Attributes

Table 112. Metware Biotechnology Inc (Metware) Revenue (US$ Million) and Gross Margin (2020-2025)

Table 113. Metware Biotechnology Inc (Metware) Recent Developments

Table 114. Biotech Pack Corporation Information

Table 115. Biotech Pack Description and Major Businesses

Table 116. Biotech Pack Product Features and Attributes

Table 117. Biotech Pack Revenue (US$ Million) and Gross Margin (2020-2025)

Table 118. Biotech Pack Recent Developments

Table 119. APPLIED PROTEIN TECHNOLOGY Corporation Information

Table 120. APPLIED PROTEIN TECHNOLOGY Description and Major Businesses

Table 121. APPLIED PROTEIN TECHNOLOGY Product Features and Attributes

Table 122. APPLIED PROTEIN TECHNOLOGY Revenue (US$ Million) and Gross Margin (2020-2025)

Table 123. APPLIED PROTEIN TECHNOLOGY Recent Developments

Table 124. Bioprofile Corporation Information

Table 125. Bioprofile Description and Major Businesses

Table 126. Bioprofile Product Features and Attributes

Table 127. Bioprofile Revenue (US$ Million) and Gross Margin (2020-2025)

Table 128. Bioprofile Recent Developments

Table 129. TianGen Corporation Information

Table 130. TianGen Description and Major Businesses

Table 131. TianGen Product Features and Attributes

Table 132. TianGen Revenue (US$ Million) and Gross Margin (2020-2025)

Table 133. TianGen Recent Developments

Table 134. Raw Materials Key Suppliers

Table 135. Distributors List

Table 136. Market Trends and Market Evolution

Table 137. Market Drivers and Opportunities

Table 138. Market Challenges, Risks, and Restraints

Table 139. Research Programs/Design for This Report

Table 140. Key Data Information from Secondary Sources

Table 141. Key Data Information from Primary Sources

List of Figures

Figure 1. Plant Metabolomics Product Picture

Figure 2. Global Plant Metabolomics Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Plant Targeted Metabolomics Product Picture

Figure 4. Plant Non-targeted Metabolomics Product Picture

Figure 5. Global Plant Metabolomics Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 6. Plant Breeding

Figure 7. Medicinal Plant Research

Figure 8. Biomarker Development

Figure 9. Food Science

Figure 10. Plant Metabolomics Report Years Considered

Figure 11. Global Plant Metabolomics Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Plant Metabolomics Revenue (2020-2031) & (US$ Million)

Figure 13. Global Plant Metabolomics Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 14. Global Plant Metabolomics Revenue Market Share by Region (2020-2031)

Figure 15. Global Plant Metabolomics Revenue Market Share Ranking (2024)

Figure 16. Tier Distribution by Revenue Contribution (2020 VS 2024)

Figure 17. Plant Targeted Metabolomics Revenue Market Share by Player in 2024

Figure 18. Plant Non-targeted Metabolomics Revenue Market Share by Player in 2024

Figure 19. Global Plant Metabolomics Revenue Market Share by Type (2020-2031)

Figure 20. Global Plant Metabolomics Revenue Market Share by Application (2020-2031)

Figure 21. North America Plant Metabolomics Revenue YoY (2020-2031) & (US$ Million)

Figure 22. North America Top 5 Players Plant Metabolomics Revenue (US$ Million) in 2024

Figure 23. North America Plant Metabolomics Revenue (US$ Million) by Type (2020 - 2031)

Figure 24. North America Plant Metabolomics Revenue (US$ Million) by Application (2020-2031)

Figure 25. US Plant Metabolomics Revenue (2020-2031) & (US$ Million)

Figure 26. Canada Plant Metabolomics Revenue (2020-2031) & (US$ Million)

Figure 27. Mexico Plant Metabolomics Revenue (2020-2031) & (US$ Million)

Figure 28. Europe Plant Metabolomics Revenue YoY (2020-2031) & (US$ Million)

Figure 29. Europe Top 5 Players Plant Metabolomics Revenue (US$ Million) in 2024

Figure 30. Europe Plant Metabolomics Revenue (US$ Million) by Type (2020-2031)

Figure 31. Europe Plant Metabolomics Revenue (US$ Million) by Application (2020-2031)

Figure 32. Germany Plant Metabolomics Revenue (2020-2031) & (US$ Million)

Figure 33. France Plant Metabolomics Revenue (2020-2031) & (US$ Million)

Figure 34. U.K. Plant Metabolomics Revenue (2020-2031) & (US$ Million)

Figure 35. Italy Plant Metabolomics Revenue (2020-2031) & (US$ Million)

Figure 36. Russia Plant Metabolomics Revenue (2020-2031) & (US$ Million)

Figure 37. Asia-Pacific Plant Metabolomics Revenue YoY (2020-2031) & (US$ Million)

Figure 38. Asia-Pacific Top 8 Players Plant Metabolomics Revenue (US$ Million) in 2024

Figure 39. Asia-Pacific Plant Metabolomics Revenue (US$ Million) by Type (2020-2031)

Figure 40. Asia-Pacific Plant Metabolomics Revenue (US$ Million) by Application (2020-2031)

Figure 41. Indonesia Plant Metabolomics Revenue (2020-2031) & (US$ Million)

Figure 42. Japan Plant Metabolomics Revenue (2020-2031) & (US$ Million)

Figure 43. South Korea Plant Metabolomics Revenue (2020-2031) & (US$ Million)

Figure 44. Australia Plant Metabolomics Revenue (2020-2031) & (US$ Million)

Figure 45. India Plant Metabolomics Revenue (2020-2031) & (US$ Million)

Figure 46. Indonesia Plant Metabolomics Revenue (2020-2031) & (US$ Million)

Figure 47. Vietnam Plant Metabolomics Revenue (2020-2031) & (US$ Million)

Figure 48. Malaysia Plant Metabolomics Revenue (2020-2031) & (US$ Million)

Figure 49. Philippines Plant Metabolomics Revenue (2020-2031) & (US$ Million)

Figure 50. Singapore Plant Metabolomics Revenue (2020-2031) & (US$ Million)

Figure 51. Central and South America Plant Metabolomics Revenue YoY (2020-2031) & (US$ Million)

Figure 52. Central and South America Top 5 Players Plant Metabolomics Revenue (US$ Million) in 2024

Figure 53. Central and South America Plant Metabolomics Revenue (US$ Million) by Type (2020-2031)

Figure 54. Central and South America Plant Metabolomics Revenue (US$ Million) by Application (2020-2031)

Figure 55. Brazil Plant Metabolomics Revenue (2020-2025) & (US$ Million)

Figure 56. Argentina Plant Metabolomics Revenue (2020-2025) & (US$ Million)

Figure 57. Middle East and Africa Plant Metabolomics Revenue YoY (2020-2031) & (US$ Million)

Figure 58. Middle East and Africa Top 5 Players Plant Metabolomics Revenue (US$ Million) in 2024

Figure 59. South America Plant Metabolomics Revenue (US$ Million) by Type (2020-2031)

Figure 60. Middle East and Africa Plant Metabolomics Revenue (US$ Million) by Application (2020-2031)

Figure 61. GCC Countries Plant Metabolomics Revenue (2020-2025) & (US$ Million)

Figure 62. Israel Plant Metabolomics Revenue (2020-2025) & (US$ Million)

Figure 63. Egypt Plant Metabolomics Revenue (2020-2025) & (US$ Million)

Figure 64. South Africa Plant Metabolomics Revenue (2020-2025) & (US$ Million)

Figure 65. Plant Metabolomics Industry Chain Mapping

Figure 66. Channels of Distribution (Direct Vs Distribution)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-29Y19622

Thu Oct 02 00:00:00 UTC 2025

Add to Cart

Global Internet Intelligent Elderly Care Service Platform Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages

Type: Report

Code: QYRE-Auto-25O19660

Thu Oct 02 00:00:00 UTC 2025

Add to Cart

Global Spatial Epigenomics Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages

Type: Report

Code: QYRE-Auto-4D20026

Thu Oct 02 00:00:00 UTC 2025

Add to Cart

Global Plant Metabolomics Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages

Type: Report

Code: QYRE-Auto-32Q19784

Thu Oct 02 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Plant Metabolomics Market Outlook, In‑Depth Analysis & Forecast to 2031

Published Date: October 2025

Report Code: QYRE-Auto-32Q19784

Global Plant Metabolomics Market Outlook, In‑Depth Analysis & Forecast to 2031

FEATURED COMPANIES

Plant Metabolomics Market Size

Plant Metabolomics Market

Report Includes:

Scope of Plant Metabolomics Market Report

Chapter Outline

FAQ for this report

How fast is Plant Metabolomics Market growing?

What is the Plant Metabolomics Market size in 2031?

Who are the main players in the Plant Metabolomics Market report?

What are the Application segmentation covered in the Plant Metabolomics Market report?

What are the Type segmentation covered in the Plant Metabolomics Market report?

FEATURED COMPANIES

RELATED REPORTS